From the category archives:

2009

Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis

by Nick on November 3, 2009

Efficacy of systemic treatments for moderate to severe plaque psoriasis: systematic review and meta-analysis

by Nick on November 1, 2009

Statin therapy in rheumatoid arthritis: a cost-effectiveness and value-of-information analysis

by Nick on November 1, 2009

Development of a population-based microsimulation model of osteoarthritis in Canada

by Nick on October 23, 2009

The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis

by Nick on September 24, 2009

The concurrent validity and responsiveness of the health utilities index (HUI 3) among patients with advanced HIV/AIDS

by Nick on September 1, 2009

Why do patients with inflammatory arthritis often score states “worse than death” on the EQ-5D? An Investigation of the EQ-5D classification system

by Nick on September 1, 2009

Quality of life of patients with advanced HIV/AIDS: measuring the impact of both AIDS-defining events and non-AIDS serious adverse events

by Nick on August 15, 2009

Economic evaluation of systemic therapies for moderate to severe psoriasis

by Nick on June 1, 2009

Statin therapy in rheumatoid arthritis: a cost-effectiveness and value-of-information analysis

by Nick on April 28, 2009

The Rheumatoid Arthritis Drug Development Model: a case study in Bayesian clinical trial simulation

by Nick on April 1, 2009

Using short-term evidence to predict six-month outcomes in clinical trials of signs and symptoms in rheumatoid arthritis

by Nick on April 1, 2009

Obesity and overweight in Canada: an updated cost-of-illness study

by Nick on April 1, 2009

The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis

by Nick on March 25, 2009

The economics of treatment in early rheumatoid arthritis

by Nick on February 1, 2009